Our laboratories use the latest cutting-edge neuroimaging methods to investigate a wide range of nervous system disorders using techniques spanning levels from single molecules and neurons to networks including the entire brain and spinal cord.
We seek to improve neurosurgical planning in epilepsy. Our current work focuses on using fMRI and the tools of neuropsychology to predict any risk to language or memory.
We investigate normal brain mechanisms of consciousness, impaired consciousness in epilepsy, and restoration of consciousness through deep brain stimulation.
We are exploring multiple techniques to better define the metabolic foundations of human glioblastoma in vivo, with the aim to improve the understanding of cancer and oncologic care in general.
We use molecular imaging to investigate the role of the innate immunity in the development and progression of Alzheimer’s disease.
We investigate the neural correlates of motor, cognitive, and behavioral problems in patients with movement disorders, especially Parkinson’s disease, using multimodal neuroimaging.
We develop automated, quantitative image-evaluation and classification methods with a focus on clinical nuclear medicine SPECT and PET brain scans.